2,4-pentanedione

2,4-pentanedione is a lipid of Fatty Acyls (FA) class. The related lipids are Butyrates.

Cross Reference

Introduction

To understand associated biological information of 2,4-pentanedione, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,4-pentanedione?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,4-pentanedione

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Purpura, Thrombocytopenic D011696 2 associated lipids
Glioma D005910 112 associated lipids
Nervous System Diseases D009422 37 associated lipids
Seizures D012640 87 associated lipids
Fetal Resorption D005327 15 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Per page 10 20 | Total 11

PubChem Associated disorders and diseases

What pathways are associated with 2,4-pentanedione

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,4-pentanedione?

There are no associated biomedical information in the current reference collection.

What functions are associated with 2,4-pentanedione?

There are no associated biomedical information in the current reference collection.

What lipids are associated with 2,4-pentanedione?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 2,4-pentanedione?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,4-pentanedione?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,4-pentanedione

Download all related citations
Per page 10 20 50 100 | Total 1027
Authors Title Published Journal PubMed Link
El-Sonbati AZ et al. Supramolecular structure and spectral studies on mixed-ligand complexes derived from β-diketone with azodye rhodanine derivatives. 2012 Spectrochim Acta A Mol Biomol Spectrosc pmid:23036937
Qader SW et al. Pharmacological mechanisms underlying gastroprotective activities of the fractions obtained from Polygonum minus in Sprague Dawley rats. 2012 Int J Mol Sci pmid:22408403
Devi PS et al. DNA Damage Protecting Activity and Free Radical Scavenging Activity of Anthocyanins from Red Sorghum (Sorghum bicolor) Bran. 2012 Biotechnol Res Int pmid:22400119
Al-Amiery AA et al. Antifungal and antioxidant activities of pyrrolidone thiosemicarbazone complexes. 2012 Bioinorg Chem Appl pmid:22400016
Chen PY et al. Sensitive and simple flow injection analysis of formaldehyde using an activated barrel plating nickel electrode. 2011 Sep-Oct J AOAC Int pmid:22165025
Nofal ZM et al. Synthesis of new pyrimidine derivatives with evaluation of their anti-inflammatory and analgesic activities. 2011 Jul-Aug Acta Pol Pharm pmid:21796933
Pircher H et al. Identification of human fumarylacetoacetate hydrolase domain-containing protein 1 (FAHD1) as a novel mitochondrial acylpyruvase. 2011 J. Biol. Chem. pmid:21878618
Pilalis E et al. Escherichia coli genome-wide promoter analysis: identification of additional AtoC binding target elements. 2011 BMC Genomics pmid:21569465
Bernocchi G et al. Developing central nervous system and vulnerability to platinum compounds. 2011 Chemother Res Pract pmid:22312552
Wu H et al. Synthesis, Crystal Structure, and Spectra Properties of the Cadmium (II) Complex with Bis(N-allylbenzimidazol-2-ylmethyl)benzylamine. 2011 Bioinorg Chem Appl pmid:22007154
Srivastava RK et al. Ameliorative effects of dimetylthiourea and N-acetylcysteine on nanoparticles induced cyto-genotoxicity in human lung cancer cells-A549. 2011 PLoS ONE pmid:21980536
Li M et al. Yeast extract promotes cell growth and induces production of polyvinyl alcohol-degrading enzymes. 2011 Enzyme Res pmid:21977311
Premkumar T et al. Shape-tailoring and catalytic function of anisotropic gold nanostructures. 2011 Nanoscale Res Lett pmid:21974964
Yang D et al. Biogenic hierarchical TiOâ‚‚/SiOâ‚‚ derived from rice husk and enhanced photocatalytic properties for dye degradation. 2011 PLoS ONE pmid:21931853
Naidek KP et al. Structure and morphology of spinel MFe2O4 (M=Fe, Co, Ni) nanoparticles chemically synthesized from heterometallic complexes. 2011 J Colloid Interface Sci pmid:21435649
Ovcharenko VI et al. "Jumping crystals": oxygen-evolving metal-nitroxide complexes. 2011 Inorg Chem pmid:21491890
Ré VE et al. Phylodynamics of hepatitis C virus subtype 2c in the province of Córdoba, Argentina. 2011 PLoS ONE pmid:21611129
Ran C et al. Non-conjugated small molecule FRET for differentiating monomers from higher molecular weight amyloid beta species. 2011 PLoS ONE pmid:21559413
Tan M and Lu ZR Integrin Targeted MR Imaging. 2011 Theranostics pmid:21547154
Pérez N et al. Reduction of iron by decarboxylation in the formation of magnetite nanoparticles. 2011 Phys Chem Chem Phys pmid:21960123